» Articles » PMID: 40050387

Gallic Acid Alleviates Ferroptosis by Negatively Regulating APOC3 and Improves Nerve Function Deficit Caused by Traumatic Brain Injury

Overview
Journal Sci Rep
Specialty Science
Date 2025 Mar 6
PMID 40050387
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) is more common than ever and is becoming a global public health issue. A variety of secondary brain injuries occur after TBI, including ferroptosis characterized by iron-dependent lipid peroxidation. Gallic acid is a kind of traditional Chinese medicine, which has many biological effects such as anti-inflammatory and antioxidant. We further investigated whether Gallic acid can improve the neurological impairment caused by ferroptosis after TBI by targeting APOC3. Weighted gene coexpression network analyses (WGCNA) and 3 kinds of machine-learning algorithms were used to find the potential biomarkers. Then the HERB database was used to select the Chinese herb that acted on the target gene APOC3. Finally, we selected Gallic acid as a drug targeting APOC3 and verified by Western blotting. The effect of Gallic acid on the improvement of neurological function was studied by Nissl staining and FJB staining. Finally, the effect of Gallic acid on the cognitive ability of TBI mice was explored through behavioral experiments. Gallic acid can inhibit the expression level of APOC3 and thus inhibit the level of ferroptosis after TBI. It can also reduce the degeneration of nerve tissue by inhibiting ferroptosis and improve the neurological function deficit. The behavioral experiment proved that Gallic acid can alleviate the behavioral cognitive impairment caused by TBI. Gallic acid can reduce ferroptosis by inhibiting APOC3, and then alleviate neurological impairment after TBI.

References
1.
Ursini F, Maiorino M . Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med. 2020; 152:175-185. DOI: 10.1016/j.freeradbiomed.2020.02.027. View

2.
Kundu S, Singh S . What Happens in TBI? A Wide Talk on Animal Models and Future Perspective. Curr Neuropharmacol. 2022; 21(5):1139-1164. PMC: 10286592. DOI: 10.2174/1570159X20666220706094248. View

2.
Kumar V, Kundu S, Singh A, Singh S . Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective. Curr Neuropharmacol. 2021; 20(1):158-178. PMC: 9199543. DOI: 10.2174/1570159X19666210609160017. View

3.
You J, Gong Y, Wu Y, Jin L, Chi Q, Sun D . WGCNA, LASSO and SVM Algorithm Revealed RAC1 Correlated M0 Macrophage and the Risk Score to Predict the Survival of Hepatocellular Carcinoma Patients. Front Genet. 2022; 12:730920. PMC: 9044718. DOI: 10.3389/fgene.2021.730920. View

4.
Podili R, Mishra K, Akkewar A, Kumar S, Prasanna Kumari Rayala V, Kulhari U . Design, synthesis, and histone deacetylase inhibition study of novel 4-(2-aminoethyl) phenol derivatives. J Biochem Mol Toxicol. 2023; 38(1):e23591. DOI: 10.1002/jbt.23591. View